Non‐invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Objective: To determine whether non‐invasive prenatal testing by maternal plasma DNA sequencing can uncover all fetal chromosome aneuploidies in one simple sequencing event. Methods: Plasma samples from 435 pregnant women at high risk for Down syndrome were collected prior to amniocentesis in three hospitals in China between March 2009 and June 2011. We sequenced the plasma DNA extracted from these samples at low coverage. We discovered that the genome representation of each of the 24 chromosomes obeyed a linear relationship to its GC content. Applying this relationship, we analysed the copy number of each of the 24 chromosomes. Full fetal karyotyping was compared with maternal plasma DNA sequencing results. Results: Among the 435 samples, 412 samples (94.7%) have full karyotyping and sequencing results. Sixty‐seven samples containing a fetal chromosome aneuploidy, including trisomy 21, trisomy 18, trisomy 13, trisomy 9, monosomy X or others, can be accurately identified with a detection sensitivity of 100% and a detection specificity of 99.71%. Normalization of the chromosome representation values against chromosomal guanine/cytosine base content is the key issue to ensure the accuracy. Conclusions: Our results indicate that non‐invasive detection of fetal chromosome aneuploidies for all 24 chromosomes in one single sequencing event is feasible. © 2013 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sequencing technologies – the next generation
Metzker, M. L. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2626 · Cited by 7,066
Accurate whole human genome sequencing using reversible terminator chemistry
Bentley, D. R., Balasubramanian, S., Swerdlow, H. P., Smith, G. P., Milton, J., Brown, C. G., Hall, K. P., Evers, D. J., Barnes, C. L., Bignell, H. R., et al. (2008) · Nature · doi:10.1038/nature07517 · Cited by 3,684
Self-citationPresence of fetal DNA in maternal plasma and serum
Lo, Y. M. D., Corbetta, N., Chamberlain, P. F., Rai, V., Sargent, I. L., Redman, C. W., & Wainscoat, J. S. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02174-0 · Cited by 3,129
Fan, H. C., & Quake, S. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010439 · Cited by 141 · cited 1×
“For any given male fetus sample j, the percentage of the fetal DNA was estimated based on the following equation: 2 * (1 xj), where xj is the ratio between the NCRgc for chromosome X of sample j with a male fetus and the average NCRgc for chromosome X of the reference samples with female fetus.(28) D.”
Method
Cited by
Gil, M. M., Quezada, M. S., Revello, R., Akolekar, R., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14791 · Cited by 807
Analysis of cell-free DNA in maternal blood in screening for aneuploidies: Updated meta-analysis
Gil, M. M., Accurti, V., Santacruz, B., Plana, M. N., & Nicolaides, K. H. (2017) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.17484 · Cited by 683
Accurate sex identification of ancient human remains using DNA shotgun sequencing
Skoglund, P., Storå, J., Götherström, A., & Jakobsson, M. (2013) · Journal of Archaeological Science · doi:10.1016/j.jas.2013.07.004 · Cited by 513
Taylor-Phillips, S., Freeman, K., Geppert, J., Agbebiyi, A., Uthman, O. A., Madan, J., Clarke, A., Quenby, S., & Clarke, A. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010002 · Cited by 410
Non‐invasive prenatal testing for aneuploidy: current status and future prospects
Benn, P., Cuckle, H., & Pergament, E. (2013) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.12513 · Cited by 326
Metadata
- Authors
- Liang, D., Lv, W., Wang, H., Xu, L., Liu, J., Li, H., Hu, L., Peng, Y., & Wu, L.
- Venue
- Prenatal Diagnosis
- Publisher
- Wiley
- Published
- 2013-01-09
- Volume
- 33
- Issue
- 5
- Pages
- 409-415
- ISSN
- 0197-3851 (ISSN-L)
- 1097-0223
- OpenAlex
- W1735697487
- Cited by
- 144
- References
- 4
- FWCI
- 23.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.